Bio-Rad Laboratories Inc (NYSE:BIO)
$ 330.53 2.17 (0.66%) Market Cap: 9.23 Bil Enterprise Value: 9.00 Bil PE Ratio: 0 PB Ratio: 1.24 GF Score: 78/100

Bio Rad Laboratories Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 07:00PM GMT
Release Date Price: $359.49 (-3.51%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. We'll go ahead and get started. Good afternoon, everybody. Welcome to the Jefferies 2023 Global Healthcare Conference. Before we get started, I hope everyone has had a productive 2 days if you've learned something from our fireside chats or some of your one-on-one meetings. I do hope when you do get back to your offices, we'd appreciate your support, definitely in the II poll. It means more than you know.

Very happy to have Bio-Rad with us at the conference again this year. Norman, CEO, Chairman, Norman Schwartz, is going to share an update on the business. We also have CFO, Ilan Daskal, here. And I will flip it over to you, Norman.

Norman D. Schwartz
Bio-Rad Laboratories, Inc. - Chairman, CEO & President

Okay. Great. Thanks, Brandon, and certainly, thanks for having us. I wanted to take a few minutes today to refresh everybody on -- really refresh on Bio-Rad and what we've accomplished over the last few years, and then to share our continuing aspirations for '23 and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot